ACE2-GFP Expressing Human Pulmonary Artery Endothelial Cells

ACE2-GFP Expressing Human Pulmonary Artery Endothelial Cells are genetically engineered primary human pulmonary artery endothelial cells that stably express ACE2 (Angiotensin-Converting Enzyme 2) fused or co-expressed with GFP (Green Fluorescent Protein). These cells provide a reliable in vitro model for studying pulmonary vascular biology, ACE2-mediated signaling pathways, viral entry mechanisms, endothelial dysfunction, inflammation, and cardiovascular or respiratory disease research. GFP expression enables convenient real-time visualization, cell tracking, imaging, and transfection monitoring.

These specialized endothelial cells maintain key endothelial characteristics such as cobblestone morphology, marker expression, and functional responsiveness under optimized culture conditions. They are valuable tools for research involving SARS-CoV-2 host interaction studies, lung injury models, vascular permeability, angiogenesis, and therapeutic screeningACE2-GFP Expressing Human Pulmonary Artery Endothelial Cells are genetically engineered primary human pulmonary artery endothelial cells that stably express ACE2 (Angiotensin-Converting Enzyme 2) fused with GFP (Green Fluorescent Protein). These cells serve as a reliable in vitro model for studying various aspects of pulmonary vascular biology, including ACE2-mediated signaling pathways, viral entry mechanisms, endothelial dysfunction, inflammation, and research related to cardiovascular or respiratory diseases. The expression of GFP allows for convenient real-time visualization, cell tracking, imaging, and monitoring of transfection.